David Price

Medicine & Life Sciences

1. Asthma 100%
2. Chronic Obstructive Pulmonary Disease 57%
3. Adrenal Cortex Hormones 37%
4. Primary Health Care 28%
5. Nebulizers and Vaporizers 24%
6. Allergic Rhinitis 20%
7. Observational Studies 14%
8. Fluticasone 13%
9. Therapeutics 11%
10. Dry Powder Inhalers 10%
11. Registries 10%
12. Rhinitis 10%
13. Cohort Studies 10%
14. 3-(2-(4-azidobenzamidino)ethyl)-5-hydroxyindole 9%
15. Bronchodilator Agents 9%
16. Databases 8%
17. Beclomethasone 8%
18. Delivery of Health Care 8%
19. Guidelines 8%
20. Prescriptions 7%
21. Randomized Controlled Trials 7%
22. Eosinophils 7%
23. Cost-Benefit Analysis 7%
24. Equipment and Supplies 7%
25. Formoterol Fumarate 6%
26. Biological Products 6%
27. MP29-02 5%
28. Costs and Cost Analysis 5%
29. azelastine 5%
30. Population 5%
31. Pragmatic Clinical Trials 5%
32. Muscarinic Antagonists 5%
33. benralizumab 5%
34. Quality of Life 5%
35. Lung 5%
36. Tiotropium Bromide 5%
37. Physicians 5%
38. Fluticasone-Salmeterol Drug Combination 5%